Magdalena Muszynska-Spielauer

Dr. Magdalena Muszynska-Spielauer


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018
Verified
Book
Open access
RRRoland Rau
Roland Rau
CBChristina Bohk-Ewald
Christina Bohk-Ewald
MMMagdalena Muszynska-Spielauer
Magdalena Muszynska-Spielauer
JVJames W. Vaupel
James W. Vaupel
This book visualizes mortality dynamics in the Lexis diagram. While the standard approach of plotting death rates is also covered, the focus in this book is on the depiction of rates of mortality improvement over age and time. This rather novel approach offers a more intuitive understanding of the underlying dynamics, enabling readers to better understand whether period- or cohort-effects were instrumental for the development of mortality in a particular country. Besides maps for single countries, the book includes maps on the dynamics of selected causes of death in the United States, such as cardiovascular diseases or lung cancer. The book also features maps for age-specific contributions to the change in life expectancy, for cancer survival and for seasonality in mortality for selected causes of death in the United States. The book is accompanied by instructions on how to use the freely available R Software to produce these types of surface maps. Readers are encouraged to use the presented tools to visualize other demographic data or any event that can be measured by age and calendar time, allowing them to adapt the methods to their respective research interests. The intended audience is anyone who is interested in visualizing data by age and calendar time; no specialist knowledge is required. This book is open access under a CC BY license.

17 November 2022 in SSM - Population Health
Verified
Journal Article
Open access
MMMagdalena Muszynska-Spielauer
Magdalena Muszynska-Spielauer
MSMartin Spielauer
Martin Spielauer
Cross-sectional data from the Survey of Health, Ageing and Retirement in Europe (SHARE) are a common source of information in comparative studies of population health in Europe. In the largest part, these data are based on longitudinal samples, which are subject to health-specific attrition. This implies that estimates of population health based on cross-sectional SHARE datasets are biased as the data are selected on the outcome variable of interest.

8 August 2022 in European Journal of Population
Verified
Journal Article
Open access
PDF file
MMMagdalena Muszynska-Spielauer
Magdalena Muszynska-Spielauer
MLMarc Luy
Marc Luy
We propose a new summary measure of population health (SMPH), the well-being-adjusted health expectancy (WAHE). WAHE belongs to a subgroup of health-adjusted life expectancy indicators and gives the number of life years equivalent to full health. WAHE combines health and mortality information into a single indicator with weights that quantify the reduction in well-being associated with decreased health. WAHE's advantage over other SMPHs lies in its ability to differentiate between the consequences of health limitations at various levels of severity and its transparent, simple valuation function. Following the guidelines of a Committee on Summary Measures of Population Health, we discuss WAHE's validity, universality, feasibility sensitivity and ensure its reproducibility. We evaluate WAHE's performance compared to life expectancy, the most commonly used indicators of health expectancy (HE) and disability-adjusted life expectancy (DALE) in an empirical application for 29 European countries. Data on health and well-being are taken from the 2018 EU-SILC, and the life tables are from Eurostat. DALE is taken from the database of the Global Burden of Disease Programme. WAHE's sensitivity to univariate and multivariate state specifications is studied using the three Minimum European Health Module health dimensions: chronic morbidity, limitations in activities of daily living, and self-rated health. The empirical tests of the indicators’ correspondence reveal that WAHE has the strongest correlation with the other SMPHs. Moreover, WAHE estimates are in agreement with all other SMPHs. Additionally, WAHE and all other SMPHs form a group of reliable indicators for studying population health in European countries. Finally, WAHE estimates are robust, regardless of whether health is defined across one or multiple simultaneous dimensions of health. We conclude that WAHE is a useful and reliable indicator of population health and performs at least as well as other commonly used SMPHs.

20 December 2021 in Comparative Population Studies
Verified
Journal Article
Open access
PDF file
MLMarc Luy
Marc Luy
MSMarkus Sauerberg
Markus Sauerberg
MMMagdalena Muszynska-Spielauer
Magdalena Muszynska-Spielauer
VLVanessa Di Lego
Vanessa Di Lego
The COVID-19 pandemic caused an increase in mortality in 2020 with a resultant decrease in life expectancy in most countries around the world. In Germany, the reduction in life expectancy at birth between 2019 and 2020 was comparatively small, at -0.20 years. The decrease was stronger among men than among women (-0.24 vs. -0.13 years) and in eastern rather than in western Germany (-0.36 vs. -0.16 years). Men in eastern Germany experienced the biggest decline in life expectancy at birth (-0.41 years). For western German men, the decline was less pronounced (-0.19 years). Among women, the decline in life expectancy at birth was also greater in eastern (-0.25 years) than in western Germany (-0.10 years). As a result of these developments, the differences in life expectancy between the two parts of Germany, and between women and men, increased compared with the previous year. Life expectancy at age 65 decreased more strongly than life expectancy at birth for both sexes and in all regions. This reflects the fact that it was mainly older age groups that were affected by the increase in mortality in 2020. This paper provides further insights into mortality changes in 2020, based on age decomposition and an analysis of lifespan inequality. We conclude that the population in eastern Germany was hit harder by the COVID-19 pandemic in 2020 than the population in the western Germany.

12 January 2026 in European Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
MMMagdalena Muszynska-Spielauer
Magdalena Muszynska-Spielauer
PGPaola Di Giulio
Paola Di Giulio
YMYuka Minagawa
Yuka Minagawa
VLVanessa Di Lego
Vanessa Di Lego
MLMarc Luy
Marc Luy
This study tests the “longevity hypothesis,” which posits that women’s greater number of years spent in poor health is primarily a direct consequence of their longer survival. We analyse gender differences in unhealthy life years (ULY) at age 50 across 22 European countries in 2015–2017. ULY was estimated using three approaches—the Sullivan method, the cross-sectional average length of healthy life, and multistate life tables—applied to four health indicators of varying severity: chronic diseases, functional limitations, self-rated health, and disability. Data were drawn from the Human Mortality Database and the Survey of Health, Ageing and Retirement in Europe. We decomposed the gender gap in ULY into a “mortality effect” (ME), reflecting differences in life years lived, and a “health effect” (HE), reflecting differences in morbidity prevalence. Women at age 50 lived more unhealthy years than men across almost all health indicators and countries. In most cases, more than half of the gender gap in ULY was attributable to the ME, indicating that women’s longer survival primarily explains their greater number of years spent in poor health. The HE showed greater variation across indicators and countries. Results were most consistent for chronic diseases and self-rated health, while functional limitations and disability yielded smaller and less consistent differences. Findings support the longevity hypothesis: women’s higher life expectancy is the main driver of their longer lifetime spent in poor health. The variation across health dimensions highlights the importance of distinguishing between them when studying gender inequalities in health.

14 February 2023 in Drug and Alcohol Review
Verified
Journal Article
Closed access
AFAgnieszka Fihel
Agnieszka Fihel
STSergi Trias‐Llimós
Sergi Trias‐Llimós
MMMagdalena Muszynska-Spielauer
Magdalena Muszynska-Spielauer
MMMarkéta Majerová
Markéta Majerová